Commentary: The opioid overdose epidemic: Evidence-based interventions
| Autor: | Peter Barglow |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Harm reduction
medicine.medical_specialty business.industry media_common.quotation_subject Psychological intervention Medicine (miscellaneous) Opioid overdose Abstinence medicine.disease Naltrexone Fentanyl Heroin 03 medical and health sciences Psychiatry and Mental health Clinical Psychology 0302 clinical medicine Opioid Medicine 030212 general & internal medicine business Intensive care medicine 030217 neurology & neurosurgery medicine.drug media_common |
| Zdroj: | The American Journal on Addictions. 27:605-607 |
| ISSN: | 1055-0496 |
| DOI: | 10.1111/ajad.12823 |
| Popis: | Background and objectives Outcome intervention data from Medicare, veteran, prison, and United States' public populations can identify best practices to decrease opioid misuse. Prescription policies for treating pain in the United States and other countries are relevant to preventing overdose. Methods Three strategies are considered: (1) Demand Reduction counsels and educates patients and current or potential opioid users about risks and treatment options to reduce motivation to consume opioids. (2) Supply Reduction limits access and dosage of opioids and co-drugs such as benzodiazepines. It encourages use of safest prescribing practices for treating pain. (3) Harm Reduction reduces opioid deaths through medication-assisted treatment (MAT) combining opioid substitution therapy (OST), provision of opioid antagonists like Naltrexone, and behavioral health services. Results Demand Reduction is often inadequate to treat severe pain or in the presence of major psychopathology like opioid abuse disorder (OUD). Among veterans, lower opioid doses for pain treatment were associated with diminished death rates. Supply Reduction interventions have disadvantages. Banning drugs has poor long-term success with prison inmates, because abstinence is difficult to enforce after discharge. Limiting opioid supplies does not increase survival rates for Medicare patients. Discussion and conclusions Sharp opioid dose restriction in outpatient treatment increases heroin and fentanyl use, explaining why recent years' decrease in United States opioid prescriptions has not reduced national mortality rates. Although Harm Reduction is the safest, most effective single approach, combining three interventions while improving pain and addiction prescribing practices is optimal. Scientific significance Scientific research needs to inform choice of opioid overuse interventions. (Am J Addict 2018;XX:1-3). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |